Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 15, 2024
RNS Number : 0426H Stifel Nicolaus Europe Limited 15 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

Polar Capital Hldgs - Form 8.3 - Renalytix PLC - Replacement

March 15, 2024
RNS Number : 0590H Polar Capital Holdings PLC 15 March 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") Amendment - this form replaces RNS number 7712G,

Rule 2.9 announcement

March 15, 2024
RNS Number : 9595G Renalytix PLC 15 March 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

Form 8.3 - Renalytix Plc

March 14, 2024
FORM 8.3 Amendment – this form replaces RNS number 3946282 , published at 16:03 on 2024-03-14 . Changes have been made to Sections 2(b ). PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code

Form 8.3 - Renalytix Plc

March 14, 2024
FORM 8.3 Amendment – this form replaces RNS number 3945654 , published at 19:24 on 2024-03-13 . Changes have been made to Sections 1(f) and 2(b ). PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover

Form 8 (DD) - Renalytix Plc

March 14, 2024
RNS Number : 9333G Harwood Capital LLP 14 March 2024   FORM 8 (DD)   PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")   1.         KEY

Form 8 (OPD)

March 14, 2024
RNS Number : 9103G Renalytix PLC 14 March 2024       Renalytix plc   (" Renalytix plc " or the "Company")     The following correction has been made to the "FORM 8 (OPD)", which was released on 8 March 2024 at 12:14am   UK time under RNS no. 1928G.       FORM 8 (OPD)   PUBLIC OPENING POSITION

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

March 14, 2024
RNS Number : 8871G Stifel Nicolaus Europe Limited 14 March 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name

KidneyIntelX™ included in KDIGO 2024 Guideline

March 14, 2024
RNS Number : 7837G Renalytix PLC 14 March 2024       THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF MAR. THE PERSON RESPONSIBLE FOR ARRANGING THE RELEASE OF THIS ANNOUNCEMENT ON BEHALF OF RENALYTIX IS JAMES MCCULLOUGH , CEO.   Renalytix plc ("Renalytix" or the "Company")  
Displaying 41 - 50 of 353